GENE ONLINE|News &
Opinion
Blog

LATEST
Taiwan’s Biotech Industry, Lackluster or Late Bloomer? A Breakdown of Policies, Hotspots, and Market Movements
2021-10-05
Oxford Nanopore Soars on London Market Debut
2021-10-05
Xencor and Janssen Join Forces Against B-cell Lymphoma in a New Billion-Dollar Deal
2021-10-05
CYTENA Bioprocess Solutions Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals
2021-10-05Partner
Kyowa Kirin, Amgen’s Atopic Dermatitis Drug Delivers Strong Results in Phase 2 Trial
2021-10-05
FDA Greenlights First and Only Treatment for Cholestatic Pruritus with ALGS
2021-10-04
FDA Approves Kite’s CAR-T Therapy for Adult Leukemia
2021-10-04
Discoverers of Temperature and Touch Receptors Win 2021 Nobel Prize in Medicine
2021-10-04
Checkpoint Inhibitors as Part of Neoadjuvant Therapy in TNBC: Should We Use Them or Not?
2021-10-03
Amicus Therapeutics Spins Off Its Gene Therapy Unit in a SPAC Deal
2021-10-02
Merck Announces Its Oral COVID-19 Drug Cuts Risk of Hospitalization and Death by 50%
2021-10-01
Wanting In on US Market, Cynata Taps Fujifilm to Advance Stem Cell Products
2021-10-01
Japan’s Otsuka Inks $890M Deal with Sunovion to Target Neurological Illness
2021-10-01
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
1 116 117 118 119 120 220
EVENT
Scroll to Top